Pfizer Teams With Distributor Jointown To Delve Deeper Into China's Rural Markets
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Pfizer Inc., like many of its Big Pharma peers is seeking out local Chinese partners to gain access to China's lower-tier cities and rural areas. To that end, the world's largest pharma company recently signed an agreement with China's third-largest pharma distributor Jointown Pharmaceutical Group Co., Ltd. to distribute Pfizer products in markets outside of big cities
You may also be interested in...
Sanofi Sees China Growth Bolstered By County Hospitals Push
Thousands of county hospitals offer significant growth opportunities for the next 10 years, says Sanofi SVP Jean-Luc Lowinski, but adds the challenges at building the market are unique for multinational drug manufacturers in China.
Sanofi Sees China Growth Bolstered By County Hospitals Push
Thousands of county hospitals offer significant growth opportunities for the next 10 years, says Sanofi SVP Jean-Luc Lowinski, but adds the challenges at building the market are unique for multinational drug manufacturers in China.
China Looks To Raise Standards As Pharma Ties Up With Large Distributors And Retailers
Pfizer’s RMB 800 million ($127 million) of annual retail pharmacy sales in China shows the growing potential of the retail channel, and regulators are taking note.